Primaquine analogues that are potentanti-Trypanosoma cruziagents in a mouse model
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 90 (5) , 467-474
- https://doi.org/10.1080/00034983.1996.11813071
Abstract
Seventy-seven primaquine analogues were evaluated for their effectiveness in reducing the parasitaemias in female albino mice (aged 4–6 weeks) which had been infected with a Brazilian strain of Trypanosoma cruzi 15 days earlier. Of the analogues tested, 23 were more effective than the reference drug, nifurtimox, and one was > 14-fold as effective as the standard and almost four times as active as primaquine itself. Certain members of the series tested warrant further evaluation.Keywords
This publication has 5 references indexed in Scilit:
- Molecular Characterization of Mexican Stocks of Trypanosoma Cruzi using Total DNAThe American Journal of Tropical Medicine and Hygiene, 1992
- Chemotherapy for Chagas' Disease: A Perspective of Current Therapy and Considerations for Future ResearchClinical Infectious Diseases, 1986
- Present status of chemotheraphy and chemoprophylaxis of human trypanosomiasis in the Western HemispherePharmacology & Therapeutics, 1979
- In search of anti-Trypanosoma cruzi drugs: new leads from a mouse modelJournal of Medicinal Chemistry, 1977
- Effect of Primaquine on Experimental Trypanosoma cruzi Infection.Experimental Biology and Medicine, 1951